Interventional Oncology Market CAGR Forecast Through 2030: Key Trends Shaping Industry Expansion

Interventional Oncology Market Report

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Interventional Oncology Market Size Forecast: How Big Could The Market Get By 2030?

The interventional oncology market has demonstrated substantial growth in recent years. It is anticipated to expand from $2.72 billion in 2025 to $2.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. This historical expansion can be ascribed to several factors: increasing global cancer incidence rates, an expansion of interventional radiology services, a growing inclination towards minimally invasive procedures, improved availability of imaging-guided devices, and heightened investments in hospital oncology.

The interventional oncology market is anticipated to exhibit robust growth in the coming years, with its size projected to reach $4.14 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period is attributed to several factors, including the increasing adoption of AI-assisted imaging guidance, a rising demand for outpatient cancer treatments, the broadening of personalized oncology approaches, growing investments in advanced ablation technologies, and an increasing focus on reducing patient recovery times. Prominent trends expected in this period include the wider acceptance of image-guided cancer therapies, a rising utilization of minimally invasive ablation procedures, the growing integration of advanced imaging modalities, an expansion of targeted tumor treatment techniques, and an enhanced focus on precision oncology.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=12688645&type=smp&name=Interventional%20Oncology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Interventional Oncology Market Development Factors: What’s Supporting Demand?

The interventional oncology market is projected to grow due to the rising prevalence of cancer. Cancer prevalence refers to the total number of individuals, both newly and previously diagnosed, who are living with a history of cancer at a given time. This increase in cancer prevalence is attributed to lifestyle-related risks such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, all of which elevate the risk of developing various cancers. Interventional oncology aids in cancer treatment by offering minimally invasive, targeted therapies that directly focus on tumors. It improves patient outcomes by minimizing damage to healthy tissue and provides faster recovery times compared to traditional treatments. For instance, in February 2024, the World Health Organization, a Switzerland-based international organization specializing in global health policy and public health initiatives, predicted over 35 million new cancer cases in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the growing prevalence of cancer is a key driver for the interventional oncology market’s expansion.

Interventional Oncology Market Segment Breakdown: Which Categories Lead On Revenue?

The interventional oncology market covered in this report is segmented –

1) By Type: Radiation Therapy Devices, Ablation Devices, Embolization Devices

2) By Technology Type: Ultrasound, Computed Tomography Guided, Magnetic Resonance-Guided

3) By Procedure: Tumor Ablation, Tumor Biopsy, Vascular Interventions, Palliative Care

4) By Application Areas: Liver Cancer, Lung Cancer, Kidney Cancer, Pancreatic Cancer, Prostate Cancer

5) By End-Users: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions

Subsegments:

1) By Radiation Therapy Devices: Linear Accelerators, Proton Therapy Systems, Brachytherapy Devices

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Irreversible Electroporation Systems

3) By Embolization Devices: Microspheres, Coil Embolization Devices, Liquid Embolic Agents, Embolic Protection Devices

Interventional Oncology Market Transformation Trends: What Innovations Are Driving Change?

Major companies within the interventional oncology market are concentrating on developing sophisticated products, such as microcatheter-based embolization systems, to deliver precise, targeted cancer therapy while minimizing damage to surrounding healthy tissue. Microcatheter-based embolization systems are medical devices that employ tiny, flexible catheters to accurately deliver embolic agents into blood vessels, intending to block or reduce blood flow, typically for treating tumors, vascular malformations, or bleeding. For instance, in March 2025, Terumo Corporation, a Japan-based medical device company, launched the Occlusafe balloon occlusion catheter, which is based on its advanced Balloon-TACE (B-TACE) therapy for the treatment of liver cancer, particularly hepatocellular carcinoma (HCC). This specialized microcatheter utilizes the pressure gradient effect to redirect blood flow and access the microcirculation, allowing for higher concentrations of therapeutic agents at the tumor site while minimizing off-target embolization. This targeted approach seeks to improve clinical outcomes in difficult-to-treat liver cancer cases by enhancing drug delivery precision and providing improved visualization during procedures.

Interventional Oncology Market Leading Players And Competitive Positioning

Major companies operating in the interventional oncology market are Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet SA, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited, Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Medtronic plc, Koninklijke Philips NV, Cook Medical Incorporated

View The Full Interventional Oncology Market Report:

https://thebusinessresearchcompany.com/report/interventional-oncology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Interventional Oncology Market Global Footprint: Which Region Leads The Market?

North America was the largest region in the interventional oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model